Preprint Article Version 1 This version is not peer-reviewed

The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.

Version 1 : Received: 15 July 2024 / Approved: 15 July 2024 / Online: 16 July 2024 (00:25:58 CEST)

How to cite: Seguí, E.; Torres Canizales, J.; Auclin, E.; Casadevall, D.; Peiro Carmona, S.; Aguilar-Company, J.; García de Herreros, M.; Laguna, J. C.; Gorria, T.; Rodríguez, M.; Gonzalez, A.; Epaillard, N.; Gavira, J.; Bolaño, V.; Tapia, J. C.; Tagliamento, M.; Teixidó, C.; Arasanz, H.; Pilotto, S.; López Castro, R.; Mielgo, X.; Urbano, C.; Recondo, G.; Diaz Pavon, M.; Bluthgen, V.; Minatta, J. N.; Lupinacci, L.; Brasó-Maristany, F.; Prat, A.; Vlagea, A.; Mezquita, L. The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.. Preprints 2024, 2024071205. https://doi.org/10.20944/preprints202407.1205.v1 Seguí, E.; Torres Canizales, J.; Auclin, E.; Casadevall, D.; Peiro Carmona, S.; Aguilar-Company, J.; García de Herreros, M.; Laguna, J. C.; Gorria, T.; Rodríguez, M.; Gonzalez, A.; Epaillard, N.; Gavira, J.; Bolaño, V.; Tapia, J. C.; Tagliamento, M.; Teixidó, C.; Arasanz, H.; Pilotto, S.; López Castro, R.; Mielgo, X.; Urbano, C.; Recondo, G.; Diaz Pavon, M.; Bluthgen, V.; Minatta, J. N.; Lupinacci, L.; Brasó-Maristany, F.; Prat, A.; Vlagea, A.; Mezquita, L. The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.. Preprints 2024, 2024071205. https://doi.org/10.20944/preprints202407.1205.v1

Abstract

Purpose: Inflammation and neutrophils play a central role in both Covid-19 disease and cancer. We aimed to assess the impact of pre-existing tumor-related inflammation on Covid-19 outcomes in patients with cancer and to elucidate the role of circulating neutrophil subpopulations. Methods: We conducted a multicenter retrospective analysis of 524 patients with cancer and SARS-CoV-2 infection, assessing the relationship between clinical outcomes and circulating inflammatory biomarkers collected before and during Covid-19 infection. Additionally, a unicenter prospective cohort provided data for an exploratory analysis, assessing the immunophenotype of circulating neutrophils and inflammatory cytokines. The primary endpoints were 30-day mortality and severity of Covid-19 disease. Results: Prior to Covid-19, 25% of patients with cancer exhibited elevated dNLR, which increase to 55% at the time of Covid-19 diagnosis. We developed the FLARE score, incorporating both tumor and infection-induced inflammation, which categorized patients into four prognostic groups. The poor prognostic group had a 30-day mortality rate of 68%, significantly higher than the 23% in the favorable group (p

Keywords

Cancer; Covid-19; dNLR; Neutrophils; IL-6

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.